Title: A Study of Hepatic Involvement in HIV Positive Patients
Authors: Dr Kavita Krishna, Dr Nitin Gadkari, Dr Vivek Doshi, Dr Arundhati Diwan, Dr Aniket Oswal, Dr Apoorva Saoji
DOI: http://dx.doi.org/10.18535/jmscr/v4i1.25
Abstract
Human immunodeficiency virus is probably the only pathogen with diverse sites of affection in human body. Not a single organ system in particular is immune to its effects. Effects are caused either directly by the virus itself or more commonly, by virtue of so called opportunistic infections and malignancies
References
Fauci A.S.Lane H.C; HIV Disease: AIDS, Related disorders, Harrison’s Principle of internal Medicine, 16th edition. MCGRAW Hill 2005; 9(7):703-839.
Housset c. Boucher O, Girard P, Immunohistochemical evidence for human immunodeficiency virus-1 infection of Liver Kupffer cells, Hum pathol 1990;21: 404-408
Schmitt M, Lafon M, Gendrault G; Primary cultures of endothelial cells from the Human liver sinusoids are permissive for hiv 1, Proc Natl Acad sci USA 1992; 89: 1582-1586.
Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastrogntrol. 1991 Jan;86(1):1-15.
AmarapurkarAD,SangleNA.Histological spectrum of liver in HIV – autopsy study.Annals of hepatology 2005;4:47-51.
Soriano V,Barreiro P, Sherman KE. The changing epidemiology of liver disease in HIV patients. AIDS Rev 2013;15:25-31.
Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H et al. Recent patterns in population-based HIV prevalence in Swaziland. PLOS one 2013;8:e 0077101.
Samuel SO, Salami TA, Adewuyi GM, Babatope E, Ekozien MI. Prevalence of urinary tract infections among a cohort of HIV positive patients accessing care in a rural health centre in Nigeria. JMicrobiol Biotech Res 2012;2:507-510.